MGH Center for Women's Mental Health

About MGH Center for Women's Mental Health

This author has not yet filled in any details.
So far MGH Center for Women's Mental Health has created 1457 blog entries.

Treatment of Panic Disorder with Antidepressants Associated with Better Outcomes

While we have focused a great deal on the emergence of mood disorders during pregnancy and the postpartum period, there is a growing body of literature that indicates that anxiety symptoms are prevalent during this [...]

By |2018-11-21T14:37:56-04:00November 21st, 2018|Pregnancy & Medications|Comments Off on Treatment of Panic Disorder with Antidepressants Associated with Better Outcomes

In Brief: Mothers with Affective Illness (Even In Remission) Have Deficits in Emotional Processing

We have long known that postpartum depression may have negative effects on the child and may contribute to deficits in social development and emotional regulation.  Exactly what mediates these effects is not so clear; however, [...]

By |2018-11-20T14:20:42-04:00November 20th, 2018|Child Outcomes, Postpartum Depression, Postpartum Psychiatric Disorders|Comments Off on In Brief: Mothers with Affective Illness (Even In Remission) Have Deficits in Emotional Processing

Pregnant Women in the US: Less Alcohol and Cigarettes, More Pot

Using data from the National Survey of Drug Use and Health between 2002 and 2016, researchers sought to study changes in the use of alcohol, cigarette, and cannabis during pregnancy in a nationally representative sample [...]

By |2018-11-19T19:33:03-04:00November 19th, 2018|Alcohol, Cannabis, Nicotine, Perinatal Substance Use|Comments Off on Pregnant Women in the US: Less Alcohol and Cigarettes, More Pot

Weekly Roundup for NOVEMBER 16, 2018: Recent Publications in Women’s Mental Health

Why do we need to identify and treat women with depression who experience during pregnancy? We have long known that postpartum depression can negatively affect the development of children, the large study from Tuovinen and [...]

By |2018-11-16T12:53:27-04:00November 16th, 2018|Weekly Roundup|Comments Off on Weekly Roundup for NOVEMBER 16, 2018: Recent Publications in Women’s Mental Health

No Increased Risk of Autism in Children Prenatally Exposed to Commonly Used Antidepressants

Concerns regarding a link between antidepressant use during pregnancy and autism emerged when two epidemiologic studies demonstrated an association between prenatal exposure to selective serotonin reuptake inhibitor antidepressants (SSRIs) with an increased risk of autism [...]

By |2018-11-14T15:53:24-04:00November 14th, 2018|Pregnancy & Medications|Comments Off on No Increased Risk of Autism in Children Prenatally Exposed to Commonly Used Antidepressants

In Brief: Being An Older Dad Associated with Worse Pregnancy Outcomes

This study is something to keep in mind when we evaluate neonatal outcomes in mothers taking psychotropic medication.  We typically consider maternal, but not paternal, characteristics as factors which may affect neonatal outcomes; however, this [...]

By |2018-11-12T19:12:16-04:00November 12th, 2018|Psychiatric Disorders During Pregnancy|Comments Off on In Brief: Being An Older Dad Associated with Worse Pregnancy Outcomes

Weekly Roundup for NOVEMBER 9, 2018: Recent Publications in Women’s Mental Health

At this top of the list, we have a study which looked at prenatal exposure to a wide array of psychotropic medications and risk for autism spectrum disorders in the offspring.  They found no association [...]

By |2018-11-13T10:58:49-04:00November 10th, 2018|Weekly Roundup|Comments Off on Weekly Roundup for NOVEMBER 9, 2018: Recent Publications in Women’s Mental Health

FDA Supports Intravenous Brexanolone for Postpartum Depression

In 2015, we first reported on SAGE-547 (SAGE Therapeutics), a new medication for the treatment of postpartum depression (PPD).  SAGE-547, now called brexanolone, is an allosteric modulator of GABAA receptors.  Since that time, Sage Therapeutics [...]

By |2018-11-10T10:02:56-04:00November 10th, 2018|Medication, Postpartum Depression, Postpartum Psychiatric Disorders, Treatment|Comments Off on FDA Supports Intravenous Brexanolone for Postpartum Depression

Weekly Roundup for NOVEMBER 2, 2018: Recent Publications in Women’s Mental Health

Uguz and colleagues present data that indicate, in a group of women with panic disorder, neonatal outcomes were worse in the women who did not get treatment.  This week’s roundup also features a lot of [...]

By |2018-11-01T12:11:38-04:00November 2nd, 2018|Weekly Roundup|Comments Off on Weekly Roundup for NOVEMBER 2, 2018: Recent Publications in Women’s Mental Health
Go to Top